{"id":"CHEMBL1083185","canonicalSmiles":"COc1cc2c(cc1Cl)C(c1cccc(Br)c1)=NCC2","inchiKey":"IKGXHBGCVQTQBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1083185","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1083998","canonicalSmiles":"CC(C)(CC1Cc2ccccc2C1)NC[C@@H](O)COc1cc(CCC(=O)O)cc(F)c1F.Cl","inchiKey":"BQGSCEAKPBWIDI-VEIFNGETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONACALERET HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1198855","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ronacaleret HCl","Ronacaleret hydrochloride","SB-751689-A"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108766","canonicalSmiles":"CCCCCCCCCCCC(=O)O","inchiKey":"POULHZVOKOAJMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DODECANOATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dodecanoic Acid","Dodecanoic Acid Anion","Lauric Acid"],"crossReferences":{"PubChem":["144209347","144213327","17388953","17389665","56462800"],"Wikipedia":["Lauric_acid"],"drugbank":["DB03017"],"chEBI":["30805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL111077","canonicalSmiles":"CCCCCCCCCCCCCC(=O)O","inchiKey":"TUNFSRHWOTWDNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MYRISTIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Myristic acid"],"crossReferences":{"PubChem":["144209050","144213098","17389652","26752895","56436661"],"Wikipedia":["Myristic_acid"],"drugbank":["DB08231"],"chEBI":["28875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1113","canonicalSmiles":"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2","inchiKey":"QWGDMFLQWFTERH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMOXAPINE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amoxapine","Asendin","Asendis","Defanyl"],"synonyms":["Amoxapine","CL 67,772","CL-67772"],"crossReferences":{"DailyMed":["amoxapine"],"PubChem":["104171096","11110675","11110676","124879022","124879024","144203615","144212669","170465376","26747067","26751577","50100159","50104205","50104206","85230879","855963","90341240"],"Wikipedia":["Amoxapine"],"drugbank":["DB00543"],"chEBI":["2675"]},"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000184845","ENSG00000149295","ENSG00000069696","ENSG00000151577","ENSG00000169676"],"count":7},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL112687","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1","inchiKey":"QCXJEYYXVJIFCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEDOBEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acedoben"],"crossReferences":{"PubChem":["144207528","170466207","17388806","85148691"],"Wikipedia":["Acedoben"],"drugbank":["DB04500"],"chEBI":["46171"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160559","canonicalSmiles":"O=C(O)c1ccc2ccccc2n1","inchiKey":"LOAUVZALPPNFOQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINALDIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinoline-2-Carboxylic Acid","Quinoline-2-Carboxylic Acid Anion"],"crossReferences":{"drugbank":["DB02428"],"chEBI":["18386"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12","inchiKey":"RTIXKCRFFJGDFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHRYSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-407436"],"crossReferences":{"PubChem":["11112354","124882275","124882277","124882278","124882279","144212652","174006352","26748373","26748375","26753723","26753724","46501295","477194","49674567"],"Wikipedia":["Chrysin"],"drugbank":["DB15581"],"chEBI":["75095"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1182247","canonicalSmiles":"CCCCCCCCCC[N+](C)(C)CCCCCCCCCC","inchiKey":"JGFDZZLUDWMUQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIDECYLDIMETHYLAMMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217824"],"drugbank":["DB04221"]},"childChemblIds":["CHEMBL224987","CHEMBL2358929"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200454","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21.Cl","inchiKey":"ZORWARFPXPVJLW-MTFPJWTKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALGANCICLOVIR HYDROCHLORIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201314","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valcyte","Valganciclovir hydrochloride"],"synonyms":["RO107-9070/194","RS-079070-194","RS-79070-194","Valganciclovir hydrochloride"],"crossReferences":{"DailyMed":["valganciclovir%20hydrochloride"],"PubChem":["144206193"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200678","canonicalSmiles":"COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C.O=S(=O)(O)O","inchiKey":"DQSGVVGOPRWTKI-QVFAWCHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATAZANAVIR SULFATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1163","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atazanavir sulfate","Reyataz"],"synonyms":["Atazanavir sulfate","BMS-232632-05"],"crossReferences":{"DailyMed":["atazanavir%20sulfate"],"chEBI":["31243"]},"count":2,"approvedIndications":["EFO_0000544","EFO_0000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for infection and hiv infection."}
{"id":"CHEMBL1200709","canonicalSmiles":"C/C=C/C(=O)N(CC)c1ccccc1C","inchiKey":"DNTGGZPQPQTDQF-XBXARRHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROTAMITON","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crotan","Eurax"],"synonyms":["Crotamiton"],"crossReferences":{"DailyMed":["crotamiton"],"PubChem":["26719689","26747823","85148369"],"Wikipedia":["Crotamiton"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949."}
{"id":"CHEMBL1200780","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O.O=S(=O)(O)O","inchiKey":"ZEUUPKVZFKBXPW-TWDWGCDDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOBRAMYCIN SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1747","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nebcin","Tobramycin Sulfate","Tobramycin Sulfate (Pharmacy Bulk)"],"synonyms":[],"crossReferences":{"PubChem":["11533057"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200843","canonicalSmiles":"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"NOFOWWRHEPHDCY-DAUURJMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLERGONOVINE MALEATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201356","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methergine","Methylergonovine maleate"],"synonyms":["Methylergometrine maleate","Methylergonovine maleate","Methylergonovinium bimaleate"],"crossReferences":{"DailyMed":["methylergonovine%20maleate"],"PubChem":["93576602"]},"count":1,"approvedIndications":["MP_0001914"],"linkedTargets":{"rows":["ENSG00000135914","ENSG00000184845"],"count":2},"linkedDiseases":{"rows":["MP_0001914"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for hemorrhage."}
{"id":"CHEMBL1200891","canonicalSmiles":"CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1.Cl","inchiKey":"WXAYTPABEADAAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENCYCLIMINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1495","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daricon"],"synonyms":["Oxiphencyclimine chloride","Oxyphencyclimine hydrochloride"],"crossReferences":{"PubChem":["144204969","170465276","26748867","56422213","855685"],"Wikipedia":["Oxyphencyclimine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200911","canonicalSmiles":"O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1","inchiKey":"VRHJBWUIWQOFLF-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUETIAPINE FUMARATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL716","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Quetiapine Fumarate","Seroquel","Seroquel Xr"],"synonyms":["ICI-204636","ZD-5077","ZM-204636"],"crossReferences":{"PubChem":["26719780","49681551"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201174","canonicalSmiles":"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O.O=P(O)(O)O","inchiKey":"GQPYTJVDPQTBQC-KLQYNRQASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAGLIPTIN PHOSPHATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1422","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Janumet Xr","Januvia"],"synonyms":["MK-0431","MK0431","ONO-5435","Sitagliptin monophosphate anhydrous","Sitagliptin monophosphate monohydrate","Sitagliptin phosphate","Sitagliptin phosphate hydrate","Sitagliptin phosphate monohydrate"],"crossReferences":{"DailyMed":["sitagliptin%20phosphate"]},"count":6,"approvedIndications":["EFO_0000712","EFO_0003774","EFO_0000612","EFO_0001360"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0000712","EFO_0000612","HP_0001943","EFO_0003774","EFO_0001360","EFO_0000400"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201207","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O","inchiKey":"VQODGRNSFPNSQE-DVTGEIKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE PHOSPHORIC ACID","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betamethasone phosphate","Betamethasone phosphoric acid"],"crossReferences":{"DailyMed":["betamethasone%20sodium%20phosphate"],"drugbank":["DB14669"],"chEBI":["68603"]},"childChemblIds":["CHEMBL1200762"],"count":2,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","HP_0030838","HP_0003418","HP_0001742","HP_0004798","EFO_1001909","EFO_0002950","EFO_1001097","HP_0006536","EFO_0002506","HP_0030833","EFO_0000676","HP_0003419","EFO_0009552","EFO_0005752","EFO_1001434"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 2 investigational indications."}
{"id":"CHEMBL1201225","canonicalSmiles":"II","inchiKey":"PNDPGZBMCMUPRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iodine","NSC-42355"],"crossReferences":{"PubChem":["144211611"],"drugbank":["DB05382"],"chEBI":["17606"]},"count":11,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1201319","canonicalSmiles":"C[C@H](N)[C@H](O)c1cccc(O)c1","inchiKey":"WXFIGDLSSYIKKV-RCOVLWMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METARAMINOL","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Metaraminol"],"crossReferences":{"Wikipedia":["Metaraminol"],"drugbank":["DB00610"],"chEBI":["6794"]},"childChemblIds":["CHEMBL2062262","CHEMBL4303541","CHEMBL3184244","CHEMBL2062343"],"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000668","EFO_0005251"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL1201465","drugType":"Unknown","blackBoxWarning":false,"name":"CHYMOTRYPSIN","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alpha chymar","Catarase","Chymar","Chymoral","Chymoral fte","Deanase dc","Zolyse","Zonulysin"],"synonyms":[".alpha.-chymotrypsin","Chymotrypsin"],"crossReferences":{"DrugCentral":["5040"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1959 and has 1 investigational indication."}
{"id":"CHEMBL1201531","drugType":"Small molecule","blackBoxWarning":false,"name":"VERATRUM VIRIDE ROOT","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vertavis"],"synonyms":["Veratrum","Veratrum viride","Veratrum viride root"],"count":1,"approvedIndications":["EFO_0000537"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for hypertension."}
{"id":"CHEMBL1201570","drugType":"Protein","blackBoxWarning":false,"name":"ANAKINRA","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antril","Kineret"],"synonyms":["AMG-719","Anakinra","Interleukin-1 receptor antagonist anakinra"],"crossReferences":{"DailyMed":["anakinra"],"DrugCentral":["5017"],"Wikipedia":["Anakinra"]},"count":47,"approvedIndications":["EFO_0000685","Orphanet_1451","Orphanet_47045","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000115594"],"count":1},"linkedDiseases":{"rows":["EFO_0003073","EFO_0001361","EFO_1000710","EFO_0004274","EFO_0007323","EFO_0010638","MONDO_0007254","EFO_0009536","EFO_0005952","EFO_1001345","EFO_0000540","EFO_0004246","Orphanet_1451","EFO_1000044","EFO_0009507","EFO_1001480","EFO_0002506","EFO_0000096","EFO_0000544","EFO_0007135","EFO_0003144","EFO_0003884","Orphanet_47045","EFO_0000253","EFO_0007427","EFO_0004238","EFO_0000400","Orphanet_342","Orphanet_379","EFO_0009609","Orphanet_797","EFO_0000616","EFO_0002618","MONDO_0005149","EFO_0000685","EFO_0009672","EFO_1001806","EFO_0000660","EFO_0002609","EFO_0003106","EFO_0000195","EFO_1001209","EFO_1001231","EFO_0003885","MONDO_0100096","EFO_1001999","EFO_0000398","EFO_0000270","EFO_0001359","EFO_0000764","EFO_0008583","EFO_0007328","EFO_0001378","MONDO_0043510","MONDO_0024880","EFO_0004540"],"count":56},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 43 investigational indications."}
{"id":"CHEMBL1201586","drugType":"Antibody","blackBoxWarning":false,"name":"PALIVIZUMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Synagis","Synagis abbosynagis"],"synonyms":["MEDI-493","Palivizumab"],"crossReferences":{"DailyMed":["palivizumab"],"DrugCentral":["4935"],"Wikipedia":["Palivizumab"]},"count":3,"approvedIndications":["EFO_0000684"],"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for respiratory system disease and has 2 investigational indications."}
{"id":"CHEMBL1201752","canonicalSmiles":"C/C(=C\\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1","inchiKey":"FABUFPQFXZVHFB-PVYNADRNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IXABEPILONE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ixempra","Ixempra kit"],"synonyms":["BMS 247550-01","BMS-247550","BMS-247550-01","Ixabepilone"],"crossReferences":{"Wikipedia":["Ixabepilone"],"drugbank":["DB04845"],"chEBI":["63605"]},"count":38,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0000292","EFO_0002938","MONDO_0004192","EFO_0000756","EFO_0000681","MONDO_0015686","EFO_1000231","MONDO_0007254","EFO_0003871","EFO_1001465","EFO_1001469","MONDO_0002087","EFO_0000305","MONDO_0020654","EFO_1001951","EFO_0000565","EFO_1001952","EFO_0000309","MONDO_0002158","EFO_0006352","EFO_1001974","MONDO_0008903","EFO_0000673","EFO_0002499","EFO_0002914","EFO_0000616","EFO_0002618","EFO_0003897","EFO_0006859","MONDO_0008170","EFO_0000349","EFO_0000403","EFO_1001968","EFO_0007535","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001967","MONDO_0044787","EFO_0003032","EFO_0006861","EFO_1000238","MONDO_0011962","EFO_0000574","EFO_1000613","MONDO_0018906","MONDO_0044926"],"count":49},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 5 approved and 33 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201770","canonicalSmiles":"C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.[Br-]","inchiKey":"IFGIYSGOEZJNBE-KNLJMPJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLNALTREXONE BROMIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1186579","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relistor"],"synonyms":["MRZ 2663BR","MRZ-2663BR","Methylnaltrexone bromide"],"crossReferences":{"DailyMed":["methylnaltrexone%20bromide"]},"count":2,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0008585","MONDO_0004567","HP_0002019"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL1209734","canonicalSmiles":"COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)Oc2cccc3ccccc23)[C@@H](O)[C@@]1(C)O","inchiKey":"YFXGICNMLCGLHJ-RSKRLRQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986094","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986094","Bms-986094","INX 08189","INX-08189","INX-089","INX-189","Inx-08189"],"crossReferences":{"drugbank":["DB11966"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1222398","canonicalSmiles":"N[C@H](CO)Cc1c[nH]c2ccccc12","inchiKey":"UDQCRUSSQAXPJY-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRYPTOPHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04236"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230308","canonicalSmiles":"CC(C)CCC(=O)O","inchiKey":"FGKJLKRYENPLQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230308","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03993"],"chEBI":["74903"]},"childChemblIds":["CHEMBL1762644"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230421","canonicalSmiles":"Cc1cn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O","inchiKey":"IGWHDMPTQKSDTL-JXOAFFINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230421","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04243"],"chEBI":["77120"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230671","canonicalSmiles":"O=c1[nH]cnc2cc[nH]c12","inchiKey":"UWMXUDUWVFWJPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-Deazahypoxanthine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Deazahypoxanthine"],"crossReferences":{"drugbank":["DB04095"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231012","canonicalSmiles":"N=C(N)c1ccc(CC(=O)C(=O)O)cc1","inchiKey":"ZXBYWYQEQQBMBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231012","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02018"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232207","canonicalSmiles":"NC(=O)CC[C@@H](N)C(=O)O","inchiKey":"ZDXPYRJPNDTMRX-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232207","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111226","144205600","170465304","26756688"],"drugbank":["DB02174"],"chEBI":["17061"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233506","canonicalSmiles":"CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)N(CCN3CCOCC3)[C@@H](C(=O)NO)C(C)C)cc2)cc1","inchiKey":"YJNCFXPJICILOK-HHHXNRCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-74020","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-74020"],"crossReferences":{"drugbank":["DB01630"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234905","canonicalSmiles":"Nc1ncc(C(=O)N(Cc2ccccc2)Cc2ccccc2)o1","inchiKey":"KIJXWOGFYAWTNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234905","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08315"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236215","canonicalSmiles":"CSc1nc2ccccc2c(=O)n1-c1c(F)cccc1F","inchiKey":"BFNBJSXMXXQLAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236215","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08602"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256739","canonicalSmiles":"CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C.Cl","inchiKey":"IPWGSXZCDPTDEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXISYLYTE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL159226","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moxisylyte HCl"],"crossReferences":{"PubChem":["144203745","170465759","50106592","56422105","855808"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256815","canonicalSmiles":"N#Cc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"LZLXHGFNOWILIY-APPDUMDISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADOFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pradofloxacin"],"crossReferences":{"drugbank":["DB11453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL13254","canonicalSmiles":"CC[C@H](C(=O)Oc1c(OC)cc(C)cc1OC)N(CCOC)CCOC","inchiKey":"GKRFHHRXDUACIN-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORG-24447","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORG-24447"],"crossReferences":{"drugbank":["DB12312"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1345","canonicalSmiles":"N=C(N)NCCN1CCCCCCC1.O=S(=O)(O)O","inchiKey":"YUFWAVFNITUSHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANETHIDINE MONOSULFATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL765","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ganda","Guanethidine monosulfate","Ismelin","Ismeline","Lotens"],"synonyms":["Guanethidine monosulfate"],"crossReferences":{"PubChem":["26748068"],"chEBI":["51016"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL134702","canonicalSmiles":"CCCC","inchiKey":"IJDNQMDRQITEOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTANE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butane","E-943","E943a","HC 600","INS NO.943","INS-943","R 600"],"crossReferences":{"Wikipedia":["Butane"],"chEBI":["37808"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1354","canonicalSmiles":"CC(=O)[O-].[Na+]","inchiKey":"VMHLLURERBWHNL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM ACETATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-262(I)","E262","FEMA NO. 3024","INS NO.262(I)","INS-262(I)","NSC-77459","Sodium Acetate","Sodium acetate","Sodium acetate anhydrous","Sodium acetate hydrate","Sodium acetate trihydrate","Sodium acetate, anhydrous"],"crossReferences":{"DailyMed":["sodium%20acetate"],"DrugCentral":["4203"],"PubChem":["144209939"],"Wikipedia":["Sodium_acetate"],"drugbank":["DB09395"],"chEBI":["32954"]},"childChemblIds":["CHEMBL2107054"],"count":2,"approvedIndications":["MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for hemorrhage and has 1 investigational indication."}
{"id":"CHEMBL1367944","canonicalSmiles":"CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1.CC(O)C(=O)O","inchiKey":"QPOFIDVRLWJICD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1367944","maximumClinicalTrialPhase":0,"parentId":"CHEMBL24072","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56463630"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1371937","canonicalSmiles":"CC(C)(CO)C(O)C(=O)NCCCO","inchiKey":"SNPLKNRPJHDVJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTHENOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Panthenol","Panthenol, racemic"],"crossReferences":{"PubChem":["144212977","56320906"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1383","canonicalSmiles":"Nc1ncnc2c1ncn2[C@H]1CC[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1","inchiKey":"OAKPWEUQDVLTCN-NKWVEPMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DDATP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ddatp"],"crossReferences":{"drugbank":["DB02189"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1437006","canonicalSmiles":"COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=C(O)C(O)C(O)C(=O)O","inchiKey":"WWXYYTOHUGNKSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1437006","maximumClinicalTrialPhase":0,"parentId":"CHEMBL723","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204984","170465440","26748946","26748947"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1441570","canonicalSmiles":"Cc1cc(=O)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12","inchiKey":"YUDPTGPSBJVHCN-YMILTQATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1441570","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49647071"],"drugbank":["DB13177"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1447","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1","inchiKey":"OJMMVQQUTAEWLP-KIDUDLJLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LINCOMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lincomycin","U-10,149","U-10149"],"crossReferences":{"DailyMed":["lincomycin%20hydrochloride"],"PubChem":["29215234"],"Wikipedia":["Lincomycin"],"drugbank":["DB01627"],"chEBI":["6472"]},"childChemblIds":["CHEMBL3989551","CHEMBL1201097","CHEMBL4075711"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for bacterial disease and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL148732","canonicalSmiles":"O=P(O)(O)C(c1ccccc1)P(=O)(O)O","inchiKey":"FRLTXWJJMCIUNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL148732","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02908"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL149502","canonicalSmiles":"Cc1c(CC(N)=O)c2cc(OCCCP(=O)(O)O)ccc2n1Cc1ccccc1","inchiKey":"AQEYCNKFBRLUOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL149502","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02504"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL153192","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)c1cc(Br)ccc1O","inchiKey":"QBSGXIBYUQJHMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOCHLOROSALICYLANILIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromochlorosalicylanilide"],"crossReferences":{"drugbank":["DB13696"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1547","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1","inchiKey":"JZRWCGZRTZMZEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaxin","Vitamin B 1"],"synonyms":["Thiamine"],"crossReferences":{"DailyMed":["thiamine%20hydrochloride"],"Wikipedia":["Thiamine"],"drugbank":["DB00152"],"chEBI":["18385"]},"childChemblIds":["CHEMBL1200941","CHEMBL1588","CHEMBL2104496"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 8 investigational indications."}
{"id":"CHEMBL155886","canonicalSmiles":"CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O","inchiKey":"CRJGESKKUOMBCT-VQTJNVASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceramide"],"crossReferences":{"chEBI":["64913"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1580221","canonicalSmiles":"CN(C)CCC(c1ccccc1)c1ccccn1.O=C(O)CC(=O)O","inchiKey":"BCGZIOMGKOBLIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1580221","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1193","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["17388784"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1591707","canonicalSmiles":"C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O.C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O.O.O.O","inchiKey":"YKFCISHFRZHKHY-NGQGLHOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1591707","maximumClinicalTrialPhase":0,"parentId":"CHEMBL459","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204468","144209229","144210800","170464643","26751786"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1595","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"RBOXVHNMENFORY-DNJOTXNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROCODEINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dihydrocodeine","IDS-ND-008(SECT.2)","NSC-231319"],"crossReferences":{"DailyMed":["dihydrocodeine%20bitartrate"],"Wikipedia":["Dihydrocodeine"],"drugbank":["DB01551"]},"childChemblIds":["CHEMBL2062266"],"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for pain."}
{"id":"CHEMBL1599248","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1.O=C(O)/C=C\\C(=O)O","inchiKey":"BCVIWCRZYPHHMQ-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEBOPRIDE MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL325109","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204257","170465853","26748881","93576603"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1611291","canonicalSmiles":"CCCCC/C(C=O)=C/c1ccccc1","inchiKey":"HMKKIXGYKWDQSV-KAMYIIQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1611291","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217974"],"drugbank":["DB14175"],"chEBI":["32318"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1614650","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](N)CC3","inchiKey":"ZVYVPGLRVWUPMP-FYSMJZIKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXATECAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Exatecan"],"crossReferences":{"Wikipedia":["Exatecan"],"drugbank":["DB12185"]},"childChemblIds":["CHEMBL3989759"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1628240","canonicalSmiles":"CC[C@@H](CO)NCCN[C@@H](CC)CO.Cl","inchiKey":"ZVRRAFGIXXGENK-IYPAPVHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMBUTOL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL44884","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1661","canonicalSmiles":"OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO","inchiKey":"VQHSOMBJVWLPSR-JVCRWLNRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTITOL","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Importal","Pizensy"],"synonyms":["E-966","INS NO.966","INS-966","Lactitol","NSC-231323"],"crossReferences":{"DailyMed":["lactitol"],"PubChem":["144205950","170465917"],"drugbank":["DB12942"],"chEBI":["75323"]},"childChemblIds":["CHEMBL1200429"],"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for constipation."}
{"id":"CHEMBL1669","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.Cl","inchiKey":"PTGMKRAMUHJZFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aralen HCl"],"synonyms":["Chloroquine HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL167691","canonicalSmiles":"CNC(=O)N(N(CCCl)S(C)(=O)=O)S(C)(=O)=O","inchiKey":"PVCULFYROUOVGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAROMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cloretazine"],"synonyms":["101M","Laromustine","VNP-40101M","VNP40101M"],"crossReferences":{"drugbank":["DB05817"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1684","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O","inchiKey":"HDWIHXWEUNVBIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDROFLUMETHIAZIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aprinox","Berkozide","Centyl","Naturetin","Naturetin-10","Naturetin-2.5","Naturetin-5","Neo-bendromax 2.5","Neo-bendromax 5","Neo-naclex","Urizide"],"synonyms":["Bendrofluazide","Bendroflumethiazide","Benzydroflumethiazide"],"crossReferences":{"DailyMed":["bendroflumethiazide"],"PubChem":["124883448","144203916","170465156","26747201","56422088","855628"],"Wikipedia":["Bendroflumethiazide"],"drugbank":["DB00436"],"chEBI":["3013"]},"count":2,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for cardiovascular disease and hypertension."}
{"id":"CHEMBL169186","canonicalSmiles":"COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1","inchiKey":"QHIMVPIOWKYPSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL169186","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07249"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1693","canonicalSmiles":"CCN(CC)C(C)C(=O)c1ccccc1.Cl","inchiKey":"ICFXZZFWRWNZMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLPROPION HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1194666","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apisate","Diethylpropion hydrochloride","Tenuate","Tenuate dospan","Tepanil","Tepanil ten-tab"],"synonyms":["Amfepramone hydrochloride","D03801","Diethylpropion HCl","Diethylpropion hydrochloride","Diethylpropion hydrochloride civ"],"crossReferences":{"DailyMed":["diethylpropion%20hydrochloride"],"PubChem":["170464650"],"chEBI":["643703"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959."}
{"id":"CHEMBL171246","canonicalSmiles":"CCC(=O)C(=O)O","inchiKey":"TYEYBOSBBBHJIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Oxo-Butyric Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxo-Butyric Acid","2-Oxobutanoate"],"crossReferences":{"Wikipedia":["Alpha-Ketobutyric_acid"],"drugbank":["DB04553"],"chEBI":["30831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1729579","canonicalSmiles":"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O","inchiKey":"BAVDEDVBIHTHJQ-UVJOBNTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LISINOPRIL HYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1237","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lisinopril","Prinivil","Zestril"],"synonyms":["Lisinopril hydrate"],"crossReferences":{"PubChem":["56463367"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742984","drugType":"Antibody","blackBoxWarning":false,"name":"AMATUXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amatuximab","MORAb-009"],"count":4,"linkedTargets":{"rows":["ENSG00000102854"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000588","EFO_0000770","EFO_0000311"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743012","drugType":"Antibody","blackBoxWarning":false,"name":"ENOKIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7F3COM-2H2","Enokizumab","MEDI 528","MEDI-528"],"count":1,"linkedTargets":{"rows":["ENSG00000145839"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1743035","drugType":"Antibody","blackBoxWarning":false,"name":"LEBRIKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lebrikizumab","MILR-1444A","MILR1444A","PRO-301444","PRO-301444 RG-3637","PRO301444","RG-3637"],"count":4,"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000768","EFO_0000341","EFO_0000274","MONDO_0004784"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL18136","canonicalSmiles":"N/C(=N\\O)N1CCC(CNC(=O)[C@@H]2CC[C@H]3CN(S(=O)(=O)Cc4ccccc4)CC(=O)N32)CC1","inchiKey":"DHTSUHWLPAEEQB-OALUTQOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL18136","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02723"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL182","canonicalSmiles":"Nc1nc(O)c2ncn(COC(CO)CO)c2n1","inchiKey":"IRSCQMHQWWYFCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GANCICLOVIR","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cymevene","Cytovene","Ganciclovir","Ganzyk-rtu","Virgan","Vitrasert","Zirgan"],"synonyms":["BW 759U","BW-759U","Cymevene","Ganciclovir","RS-21592","Valganciclovir hydrochloride impurity a"],"crossReferences":{"DailyMed":["ganciclovir"],"PubChem":["11111224","11111225","144203711","170464961","50106328","50113251","56424026","8139883","90341439"],"Wikipedia":["Ganciclovir"],"drugbank":["DB01004"],"chEBI":["465284"]},"childChemblIds":["CHEMBL1200850"],"count":19,"approvedIndications":["EFO_1001888","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and is indicated for eye infection and viral disease and has 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1877254","canonicalSmiles":"Br.CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.O","inchiKey":"UXOOBDDSNJVVBU-HXNADDDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1877254","maximumClinicalTrialPhase":0,"parentId":"CHEMBL569713","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56463622"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189","canonicalSmiles":"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1","inchiKey":"PZRHRDRVRGEVNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILRINONE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Primacor"],"synonyms":["Milrinone","WIN 47,203-2","WIN-47203-2"],"crossReferences":{"DailyMed":["milrinone%20lactate"],"PubChem":["11111460","11111461","11114110","11532967","124880718","144205666","144214030","170465221","26757809","49681694","50104873","90341667"],"Wikipedia":["Milrinone"],"drugbank":["DB00235"],"chEBI":["50693"]},"childChemblIds":["CHEMBL1200977"],"count":7,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000172572"],"count":1},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0000713","EFO_0002687","EFO_0003144","EFO_0005207","EFO_0000319","HP_0030680","EFO_1000994"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for cardiovascular disease and has 6 investigational indications."}
{"id":"CHEMBL19236","canonicalSmiles":"COc1nc(C)nc(Cl)c1NC1=NCCN1","inchiKey":"WPNJAUFVNXKLIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXONIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cynt","Fisiotens","Norcynt","Normatens","Nucynt","Physiotens"],"synonyms":["BDF-5896","BDF5896","BE-5895","BE5895","LY-326869","LY326869","Moxonidine"],"crossReferences":{"PubChem":["11111430","11111431","144203741","170466534","85148350","90341434"],"Wikipedia":["Moxonidine"],"drugbank":["DB09242"],"chEBI":["7009"]},"childChemblIds":["CHEMBL1256287"],"count":3,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000010322"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","EFO_0000401","EFO_0005252","EFO_0000618","EFO_0001073","EFO_0000692","EFO_0000660","EFO_0000537"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL1950649","canonicalSmiles":"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC[C@H]4CC[C@H](C(=O)OC)CC4)nc32)[C@H](O)[C@@H]1O","inchiKey":"FLEVIENZILQUKB-XTWQNQIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APADENOSON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stedivaze"],"synonyms":["Apadenoson","BMS-068645","BMS068645","Bms-068645"],"crossReferences":{"drugbank":["DB05009"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1957038","canonicalSmiles":"Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1","inchiKey":"ZZUBHVMHNVYXRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDRONOXIL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dehydroequol","Idronoxil","NV-06"],"crossReferences":{"PubChem":["174006673"],"drugbank":["DB04915"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1964546","canonicalSmiles":"Nc1ccc2cc3ccc(N)cc3nc2c1.O=S(=O)(O)O","inchiKey":"WSFHCKWLECYVBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROFLAVINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL55400","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-1510","Proflavine sulfate"],"crossReferences":{"PubChem":["522182","72090"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1987518","canonicalSmiles":"O=S(=O)(O)c1ccc2[nH]c(-c3ccccc3)nc2c1","inchiKey":"UVCJGUGAGLDPAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENSULIZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensulizole","Phenylbenzimidazole sulfonic acid"],"crossReferences":{"PubChem":["144205934","144208193","170465490","29218020"],"drugbank":["DB11115"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200377","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2C(F)(F)F)o1","inchiKey":"IJPNRBZMRINMMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["845165"],"drugbank":["DB07759"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028234","canonicalSmiles":"C[C@H](CCC(=O)[O-])[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C.[Na+]","inchiKey":"WDFRNBJHDMUMBL-FUXQPCDDSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2028234","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1551","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["518642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062264","canonicalSmiles":"CNC[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"NHKOTKKHHYKARN-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLEPHRINE BITARTRATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1215","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phenylephrine bitartrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973."}
{"id":"CHEMBL2103796","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](OCc2ccccc2)[C@H](C)O1.Cl","inchiKey":"GPMIHHFZKBVWAZ-LMMKTYIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERUBICIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110580","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berubicin hydrochloride","RTA 744","RTA-744","WP-744","WP744"],"count":2,"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000326","EFO_0000313"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103872","canonicalSmiles":"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1","inchiKey":"JHFNIHVVXRKLEF-DCZLAGFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOLOZANE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CXA-101","CXA-101 FREE BASE","Ceftolozane","FR-264205"],"crossReferences":{"DailyMed":["ceftolozane%20sulfate"],"drugbank":["DB09050"]},"childChemblIds":["CHEMBL1213250"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 6 investigational indications."}
{"id":"CHEMBL2104907","canonicalSmiles":"CCNC1=NC(=O)C(c2ccccc2)O1","inchiKey":"RXOIEVSUURELPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOZOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenozolone","LD 3394","Phenozolone"],"crossReferences":{"drugbank":["DB13341"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104957","canonicalSmiles":"CC(C)(C)CC(C)(C)c1cc(Cc2cc(C(C)(C)CC(C)(C)C)cc(-n3nc4ccccc4n3)c2O)c(O)c(-n2nc3ccccc3n2)c1","inchiKey":"FQUNFJULCYSSOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOCTRIZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tinosorb m"],"synonyms":["Bisoctrizole","FAT 75'634","FAT-75634","MBBT"],"crossReferences":{"PubChem":["144206094","225144291"],"drugbank":["DB11262"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105385","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCC(O)c2ccccc2)CC1","inchiKey":"IPOPQVVNCFQFRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOPERIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenoperidine","R 1406"],"crossReferences":{"drugbank":["DB13605"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108041","drugType":"Antibody","blackBoxWarning":false,"name":"OCRELIZUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ocrevus"],"synonyms":["2H7","Ocrelizumab","PR-070769","PR070769","R-1594","RG-1594"],"crossReferences":{"DailyMed":["ocrelizumab"]},"count":9,"approvedIndications":["EFO_0003840","EFO_0008520","EFO_0003929","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0000685","EFO_0003840","EFO_0002690","EFO_0008520","EFO_0003929","EFO_0007332","EFO_0005952","EFO_0000540"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 4 approved and 5 investigational indications."}
{"id":"CHEMBL2108197","drugType":"Unknown","blackBoxWarning":false,"name":"DEXTRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextrin"],"count":5,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108233","drugType":"Unknown","blackBoxWarning":false,"name":"COCOA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cocoa"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108416","drugType":"Enzyme","blackBoxWarning":false,"name":"BRINOLASE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brinase","Brinolase","CA-7","PROTEASE 1"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108659","drugType":"Unknown","blackBoxWarning":false,"name":"TRIGLYCERIDES, MEDIUM-CHAIN","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Medium chain triglycerides","Triglycerides, medium-chain"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2016 and has 1 investigational indication."}
{"id":"CHEMBL2108921","drugType":"Unknown","blackBoxWarning":false,"name":"CHOCOLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chocolate","Theobroma cacao"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108995","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOMER 910","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blephagel","Carbopol 910"],"synonyms":["Carbomer","Carbomer 910"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110618","canonicalSmiles":"CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(C(=O)OC[C@H](COC(=O)N(Cc2cccc[n+]2CC)C(=O)c2ccccc2OC)OC)CC1","inchiKey":"HGOAIWZFTWACBD-RRHRGVEJSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"MINOPAFANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-5880","Minopafant"],"childChemblIds":["CHEMBL2104419"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110938","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C1CCCCN1","inchiKey":"XSWHNYGMWWVAIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPRADROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pipradrol"],"crossReferences":{"drugbank":["DB11584"]},"childChemblIds":["CHEMBL2106720"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2133469","canonicalSmiles":"COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1.O.O=C(O)/C=C/C(=O)O","inchiKey":"AXAGNMKWGBWLMO-JITBQSAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMOTEROL FUMARATE HYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1256786","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576620"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2164775","canonicalSmiles":"CC(C)NCC(O)c1cc(O)cc(O)c1.Cl","inchiKey":"IGPZZIRRNVCAFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Rac-Metaproterenol HCl","maximumClinicalTrialPhase":0,"parentId":"CHEMBL776","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rac-Metaproterenol HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL216981","canonicalSmiles":"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1","inchiKey":"RXIUEIPPLAFSDF-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVARIXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-7123","Navarixin","PS-291822","PS291822","SCH-527123","SCH527123"],"childChemblIds":["CHEMBL2103864"],"count":3,"linkedTargets":{"rows":["ENSG00000180871","ENSG00000163464"],"count":2},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000676","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2181666","canonicalSmiles":"[18F]c1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1","inchiKey":"QWPLCHDPESWJRN-FNNGWQQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BFPET F-18","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2221306","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18f-tpp","4-[18F]Fluorophenyl)Triphenylphosphonium","Bfpet f-18"],"crossReferences":{"drugbank":["DB15424"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2218860","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOBUTROL","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gadavist"],"synonyms":["BAY86-4875","Gadobutrol","ZK 135079","ZK-135079"],"crossReferences":{"DailyMed":["gadobutrol"],"DrugCentral":["4179"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL22242","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC","inchiKey":"GUJRSXAPGDDABA-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMOXIPRIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hematological toxicity"],"year":1993},"tradeNames":[],"synonyms":["A 33547","FLA 731","Remoxipride","Roxiam"],"crossReferences":{"PubChem":["11112836","11113786","144204485","170466425","26751966"],"Wikipedia":["Remoxipride"],"drugbank":["DB00409"]},"childChemblIds":["CHEMBL1899328","CHEMBL3989556"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for psychosis. It was withdrawn in United Kingdom  in 1993 due to Hematological toxicity."}
{"id":"CHEMBL226495","canonicalSmiles":"OC[C@H]1O[C@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"BJRNKVDFDLYUGJ-ZIQFBCGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL226495","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14109"],"chEBI":["29710"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228057","canonicalSmiles":"O=C(O)[C@H]1O[C@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"HDYANYHVCAPMJV-LXQIFKJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Uridine-5'-Diphosphoglucuronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uridine-5'-Diphosphoglucuronic Acid"],"crossReferences":{"drugbank":["DB03041"],"chEBI":["17200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2315212","canonicalSmiles":"CCCC(CCC)C(=O)[O-].CCCC(CCC)C(=O)[O-].[Mg+2]","inchiKey":"LKLLHOIUJVEAGU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM VALPROATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL109","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium valproate"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL231884","canonicalSmiles":"COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O","inchiKey":"GZSOSUNBTXMUFQ-YFAPSIMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOSMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diovenor"],"synonyms":["Diosmin"],"crossReferences":{"PubChem":["144204945","170466258","50085952"],"Wikipedia":["Diosmin"],"drugbank":["DB08995"],"chEBI":["4631"]},"count":5,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL2364621","canonicalSmiles":"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O.O=S(=O)(O)CCO","inchiKey":"LYYVFHRFIJKPOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALBOCICLIB ISETHIONATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL189963","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD 0332991-0054","PD-0332991-0054","PD-03329910054","PF-00080665-73","PF-0008066573","Palbociclib isethiolate","Palbociclib isethionate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL240725","canonicalSmiles":"Cc1c(S(=O)(=O)c2ccc(=O)[nH]n2)oc2ccc(Cl)cc12","inchiKey":"FXFPQPNUMWQRAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL240725","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07187"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL242341","canonicalSmiles":"COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1","inchiKey":"HKQYGTCOTHHOMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMONONETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Formononetin","NSC-93360"],"crossReferences":{"PubChem":["11113187","124882928","124882930","144212165","174006771","26749121","26753747","399180","46501240"],"Wikipedia":["Formononetin"],"drugbank":["DB15335"],"chEBI":["18088"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL256732","canonicalSmiles":"CCCCC(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"NUNQIQQEEPOGDJ-JDOAOKHLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL256732","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258805","canonicalSmiles":"COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2","inchiKey":"QNUKRWAIZMBVCU-WCIBSUBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-9516","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-9516","Su-9516"],"crossReferences":{"PubChem":["124891674","124891675","26753623","26753624","29215168","49674687","90341527"],"drugbank":["DB03428"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260046","canonicalSmiles":"Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]","inchiKey":"UGJWRPJDTDGERK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVOFOSFAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evofosfamide","HAP-302","TH-302"],"crossReferences":{"drugbank":["DB06091"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL266497","canonicalSmiles":"O=C1NC(=O)[C@@]2(CCOc3ccc(F)cc32)N1","inchiKey":"LXANPKRCLVQAOG-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORBINIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-45,634","CP-45634","NSC-355082","Sorbinil"],"crossReferences":{"PubChem":["144205232","170466611","29215399"],"drugbank":["DB02712"],"chEBI":["102029"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL267473","canonicalSmiles":"O=C(O)c1ccc(OCCn2ccnc2)cc1","inchiKey":"XQGZSYKGWHUSDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAZOXIBEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dazoxiben","UK-37248"],"crossReferences":{"PubChem":["50104198"],"Wikipedia":["Dazoxiben"],"drugbank":["DB03052"]},"childChemblIds":["CHEMBL537708"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270687","canonicalSmiles":"CCCOc1ccnc2[nH]cc(-c3ccnc(N)n3)c12","inchiKey":"ZHMRPXZRUZLCNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERIOLIN 5","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08182"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL271227","canonicalSmiles":"CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1","inchiKey":"UVIQSJCZCSLXRZ-UBUQANBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABIRATERONE ACETATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yonsa","Zytiga"],"synonyms":["Abiraterone acetate","CB-7630","CB7630"],"crossReferences":{"DailyMed":["abiraterone%20acetate"],"PubChem":["144207138"],"chEBI":["68639"]},"count":13,"approvedIndications":["EFO_0000616","EFO_0000673","EFO_0000196","EFO_0001663","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000148795"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","MONDO_0008315","EFO_0003060","EFO_0001663","EFO_0000311","Orphanet_418","EFO_0003826","HP_0000083","Orphanet_90794","EFO_1000499","EFO_0001421","EFO_0000673","EFO_0000196","MONDO_0024880"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 5 approved and 8 investigational indications."}
{"id":"CHEMBL272690","canonicalSmiles":"CC(C)C(=O)COc1nc(N)nc2nc[nH]c12","inchiKey":"BEXUQVHWMLPYKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL272690","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03663"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278315","canonicalSmiles":"COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)NC(=CC1=O)C2=O","inchiKey":"QTQAWLPCGQOSGP-KSRBKZBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GELDANAMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Geldanamycin","NSC-122750"],"crossReferences":{"PubChem":["26756833","26756834"],"Wikipedia":["Geldanamycin"],"drugbank":["DB02424"],"chEBI":["5292"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL279260","canonicalSmiles":"C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1","inchiKey":"FHEYFIGWYQJVDR-ACJLOTCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAFABEGRON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-9677","Aj-9677","Rafabegron","TAK-677"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL283754","canonicalSmiles":"CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O","inchiKey":"BZMKNPGKXJAIDV-VAWYXSNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINALUKAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinalukast","RO 24-5913","Ro-24-5913"],"crossReferences":{"PubChem":["144204742","170466361","26753192"],"drugbank":["DB00587"],"chEBI":["126598"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL304253","canonicalSmiles":"Cc1ccc(N=C2NCCN2)c(Cl)c1","inchiKey":"KWBTZIFLQYYPTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLONIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST 375","Tolonidine"],"crossReferences":{"drugbank":["DB13429"]},"childChemblIds":["CHEMBL3275012"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL304902","canonicalSmiles":"CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"KAAZGXDPUNNEFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOTHIAPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clothiapine","Clotiapine","HF-2159"],"crossReferences":{"PubChem":["144205332","170465938","26754613","29216068"],"Wikipedia":["Clotiapine"],"drugbank":["DB13256"]},"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000135914","ENSG00000069696","ENSG00000149305","ENSG00000102468","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736","ENSG00000147246"],"count":9},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL3137304","canonicalSmiles":"Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](O)(C(F)(F)F)CC[C@@]21Cc1ccccc1","inchiKey":"QJJBNCHSWFGXML-KEKPKEOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAGROCORAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dagrocorat","PF-00251802"],"crossReferences":{"drugbank":["DB14676"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL316160","canonicalSmiles":"Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O","inchiKey":"SKTFQHRVFFOHTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMABROM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pamabrom"],"crossReferences":{"PubChem":["144206112","170465479","50112818"],"drugbank":["DB14018"]},"childChemblIds":["CHEMBL2104825"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182372","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.O.O=S(=O)(O)O","inchiKey":"JPKKQJKQTPNWTR-CHYDPLAESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182372","maximumClinicalTrialPhase":0,"parentId":"CHEMBL517712","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212490"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183740","canonicalSmiles":"NC(=O)Cn1c(=O)cc(CCN2CCN(c3nccc4sccc34)CC2)c2ccc(F)cc21","inchiKey":"JDLYOFUDIKMYBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRELANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SL65.0472","Sl650472","Trelanserin"],"crossReferences":{"PubChem":["144210557"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3184143","canonicalSmiles":"N=C(N)NCC1COC2(CCCCC2)O1.N=C(N)NCC1COC2(CCCCC2)O1.O=S(=O)(O)O","inchiKey":"RTEVGQJRTFFMLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANADREL SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1037","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hylorel"],"synonyms":["CL-1388R","Guanadrel sulfate","U-28,288D"],"crossReferences":{"PubChem":["144204146"],"chEBI":["5556"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3187985","canonicalSmiles":"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.Cl.O","inchiKey":"CXWQXGNFZLHLHQ-DPFCLETOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187985","maximumClinicalTrialPhase":0,"parentId":"CHEMBL53","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144210030","144213789"],"chEBI":["31228"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL319139","canonicalSmiles":"CCOCn1c(Cc2cc(C)cc(C)c2)c(C(C)C)c(=O)[nH]c1=O","inchiKey":"NVGVZWUORYLPAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL319139","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07820"],"chEBI":["42702"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL323799","canonicalSmiles":"O=C1NC(=O)[C@@]2(N1)O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O","inchiKey":"HVXIMXHBUJADCC-GTBMBKLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOHYDANTOCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphohydantocidin"],"crossReferences":{"drugbank":["DB02493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3330650","canonicalSmiles":"O=C(NOCCO)c1ccc2cncn2c1Nc1ccc(I)cc1F","inchiKey":"RFWVETIZUQEJEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11982"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3359265","canonicalSmiles":"Cc1nc2ccc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2[nH]1","inchiKey":"BDXXSFOJPYSYOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05175157","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-05175157"],"crossReferences":{"drugbank":["DB12096"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL339996","canonicalSmiles":"CS(=O)(=O)Nc1ccc(C(=O)O)cc1","inchiKey":"SROHFTOYGFCJAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-(Methylsulfonamido)Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(Methylsulfonamido)Benzoic Acid","4-Methanesulfonylamino-Benzoic Acid"],"crossReferences":{"drugbank":["DB07114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL34921","canonicalSmiles":"Cn1c(=O)[nH]c2c(=O)[nH]c(=O)[nH]c21","inchiKey":"XJEJWDFDVPDMAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL34921","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03293"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544946","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06291874","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06291874","Pf-06291874"],"count":1,"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3544963","drugType":"Small molecule","blackBoxWarning":false,"name":"DS-3078A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ds-3078a"],"count":1,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545065","canonicalSmiles":"CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1","inchiKey":"VDYRZXYYQMMFJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEROSUDIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-12286","AR-12286 FREE BASE","Ar-12286","Verosudil"],"childChemblIds":["CHEMBL3545124"],"count":2,"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["EFO_1001069","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545107","drugType":"Small molecule","blackBoxWarning":false,"name":"GRC-6211","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Grc-6211"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545119","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-794833","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-794833"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545275","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2623091","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly2623091"],"count":2,"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","EFO_1002032"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545322","drugType":"Small molecule","blackBoxWarning":false,"name":"PANULISIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P7170","Panulisib"],"count":1,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000139567","ENSG00000117461","ENSG00000198793"],"count":10},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545392","drugType":"Small molecule","blackBoxWarning":false,"name":"MT-3995","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apararenone","MT-3995","Mt-3995"],"count":2,"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","EFO_1001249"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3586436","canonicalSmiles":"Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4c(F)cccc4-n4nccn4)C[C@H]3C2)n1","inchiKey":"SQOCEMCKYDVLMM-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3586436","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3617964","canonicalSmiles":"Cc1c(-c2ccnn2C)cc(C(=O)NCc2ccc(S(C)(=O)=O)cn2)c(=O)n1-c1cccc(C(F)(F)F)c1","inchiKey":"QNQZWEGMKJBHEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVELESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-9668","AZD9668","Alvelestat","Azd9668"],"crossReferences":{"drugbank":["DB11863"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL362558","canonicalSmiles":"O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2","inchiKey":"HRJWTAWVFDCTGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2090314","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2090314","LY2090314","Ly 2090314","Ly-2090314"],"crossReferences":{"PubChem":["103905564"],"drugbank":["DB11913"]},"count":3,"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0002618","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL365795","canonicalSmiles":"CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1","inchiKey":"GUHPRPJDBZHYCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAPROFENIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surgam 200","Surgam 300","Surgam sa"],"synonyms":["RU 15060","Tiaprofenic acid"],"crossReferences":{"PubChem":["144204178","170465577","56463054"],"Wikipedia":["Tiaprofenic_acid"],"drugbank":["DB01600"],"chEBI":["32221"]},"count":1,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL3707278","drugType":"Antibody","blackBoxWarning":false,"name":"CROTEDUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crotedumab","REGN-1193","REGN1193"],"count":1,"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL378104","canonicalSmiles":"COc1cc(O)cc(O)c1C(=O)/C=C/c1ccccc1","inchiKey":"NYSZJNUIVUBQMM-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARDAMOMIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cardamomin","Cardamonin"],"crossReferences":{"PubChem":["24841437"],"Wikipedia":["Cardamomin"],"drugbank":["DB14122"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833353","canonicalSmiles":"CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O","inchiKey":"DTPWZYSUQQHRKD-VIUAGAKSSA-N","drugType":"Protein","blackBoxWarning":true,"name":"PRAMLINTIDE ACETATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103758","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Symlin","Symlinpen"],"synonyms":["AC0-137","AC0137","Pramlintide acetate"],"count":3,"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0001359","EFO_0001360","EFO_0001073"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3948879","canonicalSmiles":"[2H]C1(N2CC(CC#N)(n3cc(-c4ncnc5[nH]ccc45)cn3)C2)CCN(C(=O)c2ccnc(C(F)(F)F)c2F)CC1","inchiKey":"KTBSXLIQKWEBRB-OKWSDYJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3948879","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3622820","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989740","canonicalSmiles":"CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O","inchiKey":"HALQELOKLVRWRI-VDBOFHIQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXYCYCLINE HYCLATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acticlate","Acticlate cap","Alodox","Atridox","Cyclodox","Demix 100","Demix 50","Doryx","Doryx mpc","Doxatet","Doxy","Doxy 100","Doxy 200","Doxy-Caps","Doxy-lemmon","Doxychel hyclate","Doxycycline hyclate","Doxylar","Lymepak","Nordox","Periostat","Ramysis","Vibra-tabs","Vibramycin","Vibramycin 50","Vibramycin Hyclate","Vibramycin acne pack","Vibramycin-d","Vibrox"],"synonyms":["Doxycycline hyclate","Doxycycline hydrochloride hemiethanolate hemihydrate","Doxycycline hydrochloride hydrate"],"crossReferences":{"DailyMed":["doxycycline%20hyclate"]},"count":6,"approvedIndications":["EFO_0003894"],"linkedTargets":{"rows":["ENSG00000196611","ENSG00000137745","ENSG00000118113","ENSG00000137673"],"count":4},"linkedDiseases":{"rows":["EFO_1000760","EFO_0007205","EFO_0001365","EFO_0000649","EFO_1001898","Orphanet_774","EFO_0004607","EFO_1000961","EFO_0003894"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for acne and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989904","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@]12C","inchiKey":"PENDGIOBPJLVBT-AMXFZXBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETHROMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-195773","ABBOTT-195773","ABT-773","Cethromycin"],"crossReferences":{"drugbank":["DB06419"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989971","canonicalSmiles":"CC[C@H]1C[C@@H](C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2NC(C)=O)[C@@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LYSYOXNOOPBOSC-NGSKMYNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UPROLESELAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMI-1271","GMI-1271 FREE ACID","Uproleselan"],"crossReferences":{"drugbank":["DB14829"]},"childChemblIds":["CHEMBL3989975"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL399510","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC","inchiKey":"GIYAQDDTCWHPPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromopride"],"crossReferences":{"PubChem":["104171315","11112553","144204094","170466299","56463076"],"Wikipedia":["Bromopride"],"drugbank":["DB09018"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL405821","canonicalSmiles":"NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1","inchiKey":"SCTZUZTYRMOMKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SENICAPOC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ICA-17043","PF-05416266","Senicapoc"],"crossReferences":{"drugbank":["DB06280"]},"count":2,"linkedTargets":{"rows":["ENSG00000104783"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","Orphanet_3202","MONDO_0100096","Orphanet_232","EFO_0000270","EFO_0010638"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL406","canonicalSmiles":"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"NDDAHWYSQHTHNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDAPAMIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardide sr","Ethibide xl","Indapamide","Indaxa 2.5","Indipam xl","Lozol","Mapemid xl","Natrilix","Natrilix sr","Nindaxa 2.5","Opumide 2.5","Rawel xl","Tensaid xl","Varbim xl"],"synonyms":["Indapamide","KYD-041","S-1520","SE-1520"],"crossReferences":{"DailyMed":["indapamide"],"PubChem":["124883405","144204326","144206733","144213004","170465366","26747199","56422467","855885"],"Wikipedia":["Indapamide"],"drugbank":["DB00808"],"chEBI":["5893"]},"count":3,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0004253","EFO_0000319","EFO_0001360","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for hypertension and cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL40733","canonicalSmiles":"N[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21","inchiKey":"SRPXSILJHWNFMK-ZBEGNZNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESMETHYLSERTRALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desmethylsertraline"],"crossReferences":{"drugbank":["DB14071"]},"childChemblIds":["CHEMBL1743864"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL413965","canonicalSmiles":"O=C(O)Cc1ccc(-c2ccccc2)cc1","inchiKey":"QRZAKQDHEVVFRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FELBINAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolinac","Flexfree","Napageln","Target","Traxam"],"synonyms":["CL 83,544","CL-83544","Felbinac","Felbinac ethyl","LJC 10,141","LJC-10141","NSC-16284"],"crossReferences":{"PubChem":["11112568","144204100","170465835","855761"],"Wikipedia":["Felbinac"],"drugbank":["DB07477"],"chEBI":["31597"]},"childChemblIds":["CHEMBL141152"],"count":6,"approvedIndications":["HP_0002829","HP_0003326"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for myalgia and arthralgia and has 4 investigational indications."}
{"id":"CHEMBL418995","canonicalSmiles":"O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21","inchiKey":"ONNOFKFOZAJDHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINEPTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," Thailand"],"classes":["Dermatological toxicity"," Misuse"],"year":1999},"tradeNames":[],"synonyms":["Amineptine"],"crossReferences":{"PubChem":["144206864"],"Wikipedia":["Amineptine"],"drugbank":["DB04836"],"chEBI":["32499"]},"childChemblIds":["CHEMBL1697712"],"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000184845","ENSG00000149295"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression. It was withdrawn in France and  Thailand initially in 1999 due to Dermatological toxicity and  Misuse."}
{"id":"CHEMBL4297182","canonicalSmiles":"COCCN1C(=O)O[C@@]2(C[C@H]3O[C@]2(C)n2c4ccccc4c4c5c(c6c7ccccc7n3c6c42)C(=O)NC5)C1=O","inchiKey":"SHWPFRVVBIKGAT-LYWBODIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEGCANTRATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-327","CT327","Ct-327","Pegcantratinib","SNA-120","Sna-120"],"count":4,"linkedTargets":{"rows":["ENSG00000198400"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_1001494","EFO_0000676","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297254","canonicalSmiles":"CS(=O)(=O)O.N=C(NCCCCc1ccc(OCC(O)CO)cc1)NC(=O)c1nc(Cl)c(N)nc1N","inchiKey":"ZYOATBKPEFZNGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"552-02","maximumClinicalTrialPhase":2,"parentId":"CHEMBL212432","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["552-02","PS-552-02"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297275","canonicalSmiles":"Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Cl","inchiKey":"NGGRGTWYSXYVDK-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTOCHLOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytochlor","NSC-371331"],"crossReferences":{"drugbank":["DB12383"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297309","canonicalSmiles":"CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1.O=P(O)(O)O","inchiKey":"LWHMGALTTIYPJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSI-189 PHOSPHATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4302505","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nsi-189 phosphate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297382","canonicalSmiles":"CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"FOPALECPEUVCTL-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GPI-1485","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GPI 1485","Gpi 1485","Gpi-1485"],"crossReferences":{"drugbank":["DB05814"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297427","canonicalSmiles":"O[C@@]1(c2ncccn2)C[C@@H]2CC[C@H](C1)N2C(c1ccccc1Cl)c1ccccc1Cl","inchiKey":"MQWMHMZNBGQNMT-XHNJZIHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCH-486757","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH 486757","SCH486757","Sch 486757","Sch-486757"],"crossReferences":{"drugbank":["DB12782"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297564","drugType":"Unknown","blackBoxWarning":false,"name":"COBITOLIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobitolimod"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297658","canonicalSmiles":"O=C(O)[C@@H]1CCCN1.OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"TUVGWWULBZIUBS-FVYIYGEMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRAGLIFLOZIN L-PROLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipragliflozin l-proline"],"count":1,"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297705","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986178","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986178","Bms 986178","Bms-986178"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297712","drugType":"Unknown","blackBoxWarning":false,"name":"C16G2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C16G2","C16g2","STAMP C16G2"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297742","drugType":"Unknown","blackBoxWarning":false,"name":"DIAMMONIUM GLYCYRRHIZINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diammonium glycyrrhizinate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297761","drugType":"Protein","blackBoxWarning":false,"name":"GLEPAGLUTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glepaglutide","ZP-1848","ZP1848","Zp1848"],"count":3,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297791","drugType":"Unknown","blackBoxWarning":false,"name":"MVT-5873","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUMAB-5B1","MVT-5873","Mvt-5873"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297911","drugType":"Antibody","blackBoxWarning":false,"name":"SPESOLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-655130","BI655130","Bi655130","Spesolimab"],"count":4,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298007","drugType":"Protein","blackBoxWarning":false,"name":"ONFEKAFUSP ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L19tnf","Onfekafusp alfa"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298122","drugType":"Unknown","blackBoxWarning":false,"name":"CHLOROTOXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorotoxin","TM-601","TM601","Tm 601","Tm-601"],"count":8,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL441920","canonicalSmiles":"C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(=O)O","inchiKey":"QVFLVLMYXXNJDT-CSBVGUNJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL441920","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14554"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL442687","canonicalSmiles":"O=c1oc2cc(O)ccc2s1","inchiKey":"SLYPOVJCSQHITR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOXOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thioxolone","Tioxolone"],"crossReferences":{"PubChem":["144204937","174006774","26748702","56322573","93576641"],"Wikipedia":["Tioxolone"],"drugbank":["DB13343"],"chEBI":["568021"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL447627","canonicalSmiles":"O=C(O)CNC(=O)c1cccc(O)c1","inchiKey":"XDOFWFNMYJRHEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxyhippuric Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxyhippuric Acid"],"crossReferences":{"drugbank":["DB07069"],"chEBI":["70824"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL451887","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1","inchiKey":"BLMPQMFVWMYDKT-NZTKNTHTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CARFILZOMIB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kyprolis"],"synonyms":["Carfilzomib","PR-171"],"crossReferences":{"DailyMed":["carfilzomib"],"PubChem":["124955654","144206630","170466878"],"drugbank":["DB08889"],"chEBI":["65347"]},"count":27,"approvedIndications":["EFO_0000616","EFO_0001378","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000100804"],"count":1},"linkedDiseases":{"rows":["EFO_1001469","EFO_0005952","EFO_0000565","EFO_0000096","EFO_0000183","EFO_1000785","EFO_0009441","EFO_0000616","MONDO_0013730","MONDO_0019465","EFO_0000220","EFO_0000403","EFO_1001875","MONDO_0008315","EFO_0006738","EFO_0000311","EFO_0000211","EFO_0000304","MONDO_0002120","MONDO_0001023","EFO_0000095","EFO_0006475","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_1001051","EFO_0001378","MONDO_0018906","MONDO_0024880","Orphanet_314701"],"count":30},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 3 approved and 24 investigational indications."}
{"id":"CHEMBL4594315","drugType":"Gene","blackBoxWarning":false,"name":"TIMREPIGENE EMPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AAV2-REP1","Aav2-rep1","NSR-REP1","Timrepigene emparvovec"],"count":1,"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594446","canonicalSmiles":"O=C(c1cc(Cl)c(O)c(Cl)c1)N1CS(=O)(=O)c2ccccc21","inchiKey":"VOFLAIHEELWYGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOTINURAD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dotinurad","FYU-981","Fyu-981"],"count":1,"linkedTargets":{"rows":["ENSG00000197891"],"count":1},"linkedDiseases":{"rows":["EFO_0009104"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594588","drugType":"Unknown","blackBoxWarning":false,"name":"FIBRINOGEN HUMAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Factor i (fibrinogen)","Fibrinogen","Fibrinogen human","Raplixa"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594603","drugType":"Unknown","blackBoxWarning":false,"name":"LONOCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lonoctocog alfa","Rviii-singlechain"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594608","drugType":"Antibody","blackBoxWarning":false,"name":"AXATILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axatilimab","SNDX-6352","Sndx-6352","UCB-6352","UCB6352"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL475251","canonicalSmiles":"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC","inchiKey":"NHHQJBCNYHBUSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-406","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-406"],"crossReferences":{"PubChem":["103904600","137275829","99460878"],"drugbank":["DB07159"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL480853","canonicalSmiles":"C=C1CC[C@H]2[C@@](C)(CCC[C@@]2(C)CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1CCC1=CCOC1=O","inchiKey":"YGCYRQKJYWQXHG-RDNQFMDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEOANDROGRAPHOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neoandrographolide"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL482708","canonicalSmiles":"CN(c1nccc(-c2cnc3ccccn23)n1)C1CCCCC1","inchiKey":"HYNNWLVWJXWXFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL482708","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08023"],"chEBI":["78508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL496634","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCCC(=O)O","inchiKey":"YUFFSWGQGVEMMI-JLNKQSITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCOSAPENTAENOIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Docosapentaenoic acid"],"crossReferences":{"PubChem":["26754943","26754944"],"chEBI":["53488"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL51085","canonicalSmiles":"O=c1c2ccccc2[se]n1-c1ccccc1","inchiKey":"DYEFUKCXAQOFHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EBSELEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DR-3305","DR3305","Ebselen","NSC-639762","SPI-1005"],"crossReferences":{"PubChem":["11111148","11111149","124880036","124880040","144203691","26751591","50100237","50104231","50104232","50123266","50123267","56373765","56422439","85231032","856002","90341336"],"Wikipedia":["Ebselen"],"drugbank":["DB12610"],"chEBI":["77543"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL515774","canonicalSmiles":"CCCCOc1nc(NCCN2CCOCC2)c2ncn(Cc3c(F)cccc3F)c2n1","inchiKey":"UGZWPZWADDDTRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL515774","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07937"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL519827","canonicalSmiles":"CCOC(=O)c1c(C)nn(-c2ccccc2Cl)c1C","inchiKey":"XQCKNCFQOJFQFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL519827","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03807"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL522038","canonicalSmiles":"CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(/C(N)=N\\O)cc1)C1CCCCC1","inchiKey":"ZXIBCJHYVWYIKI-PZJWPPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XIMELAGATRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Worldwide"],"year":2006},"tradeNames":["Exanta (proposed)"],"synonyms":["Exanta","H 376/95","Ximelagatran"],"crossReferences":{"PubChem":["144207182"],"Wikipedia":["Ximelagatran"],"drugbank":["DB04898"],"chEBI":["65172"]},"count":3,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0000275","HP_0004419"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for recurrent thrombophlebitis and has 2 investigational indications. It was withdrawn in Worldwide  in 2006."}
{"id":"CHEMBL525610","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C","inchiKey":"OGBMKVWORPGQRR-UMXFMPSGSA-N","drugType":"Protein","blackBoxWarning":true,"name":"TERIPARATIDE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bonsity","Forsteo","Forteo"],"synonyms":["LY 333334","LY-333334","LY333334","Teriparatide","Teriparatide recombinant human","ZT-034"],"crossReferences":{"DailyMed":["teriparatide"]},"count":13,"approvedIndications":["EFO_0003882"],"linkedTargets":{"rows":["ENSG00000160801"],"count":1},"linkedDiseases":{"rows":["EFO_0003943","EFO_0000685","HP_0002901","EFO_0009451","HP_0003418","Orphanet_666","EFO_0003882","EFO_0003964","HP_0000938","EFO_0003931","EFO_0002506","EFO_0003854","EFO_0003957","EFO_1001378","EFO_0004616","EFO_0007490"],"count":16},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for osteoporosis and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL540115","canonicalSmiles":"COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1.Cl","inchiKey":"JBATXHVGRZMYGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCH-420814","maximumClinicalTrialPhase":0,"parentId":"CHEMBL240624","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH-420814"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL574431","canonicalSmiles":"O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21","inchiKey":"OHTXTCNTQJFRIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFOBROMOPHTHALEIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfobromophthalein"],"crossReferences":{"drugbank":["DB13215"],"chEBI":["63836"]},"childChemblIds":["CHEMBL453904"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL589390","canonicalSmiles":"Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1","inchiKey":"JNODQFNWMXFMEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATREPIRDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimebolin","Latrepirdine"],"crossReferences":{"PubChem":["104223880","85146210"],"drugbank":["DB11725"]},"childChemblIds":["CHEMBL1088975","CHEMBL2105703"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL61593","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O","inchiKey":"BOCUKUHCLICSIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOTHIAZIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anhydron","Fluidil"],"synonyms":["35483","Cyclothiazide"],"crossReferences":{"PubChem":["144203675","170465274","26751850","50104549","50104550","56424127","85230990"],"Wikipedia":["Cyclothiazide"],"drugbank":["DB00606"],"chEBI":["31448"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cardiovascular disease."}
{"id":"CHEMBL66","canonicalSmiles":"O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O","inchiKey":"CXQWRCVTCMQVQX-LSDHHAIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-TAXIFOLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cianidanol"],"crossReferences":{"PubChem":["26719897","26719898","49681666","56463005"],"Wikipedia":["Taxifolin"],"drugbank":["DB02224"],"chEBI":["17948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL796","canonicalSmiles":"COC(=O)C(c1ccccc1)C1CCCCN1","inchiKey":"DUGOZIWVEXMGBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHYLPHENIDATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Concerta","Cotempla xr-odt","Daytrana"],"synonyms":["Concerta","Methylin","Methylphenidate"],"crossReferences":{"DailyMed":["methylphenidate","methylphenidate%20hydrochloride"],"Wikipedia":["Methylphenidate"],"drugbank":["DB00422"],"chEBI":["84276"]},"childChemblIds":["CHEMBL1722"],"count":28,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0002610","Orphanet_232","EFO_0004216","MONDO_0002009","HP_0000726","EFO_0000249","EFO_0005252","EFO_0003768","EFO_0009267","EFO_0003829","HP_0100543","EFO_0000289","MONDO_0002050","MONDO_0045054","EFO_0000712","EFO_0004701","HP_0012378","EFO_0004242","EFO_0005230","Orphanet_797","EFO_0003888","EFO_0005203","EFO_0007625","EFO_0001642","EFO_0002508","EFO_0005323","Orphanet_636","EFO_0003929","EFO_0001358","EFO_0010445","MONDO_0008315","EFO_0001663","EFO_0000311","EFO_0003885","EFO_0003840","EFO_0003890","HP_0002045","EFO_0005611","MONDO_0043510","EFO_0003833","MONDO_0024880"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for attention deficit hyperactivity disorder and has 27 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL90983","canonicalSmiles":"COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC","inchiKey":"ORQFDHFZSMXRLM-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERAMEPROCOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EM 1421","EM-1421","Terameprocol"],"crossReferences":{"drugbank":["DB12226"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL92277","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cc(F)ccc3O)nc2c1","inchiKey":"JOGOACSSLJEREC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL92277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL92870","canonicalSmiles":"Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"ZBIAKUMOEKILTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIDOFLAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angex","Clinium"],"synonyms":["Lidoflazine","MCN-JR-7904","R 7904"],"crossReferences":{"PubChem":["11112534","144204084","170466621","174006628","56463026"],"drugbank":["DB13766"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL98","canonicalSmiles":"O=C(CCCCCCC(=O)Nc1ccccc1)NO","inchiKey":"WAEXFXRVDQXREF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VORINOSTAT","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zolinza"],"synonyms":["MK-0683","MK0683","Vorinostat"],"crossReferences":{"DailyMed":["vorinostat"],"PubChem":["104171411","124893442","144206158","144207172","170465180","49645508","50113029"],"Wikipedia":["Vorinostat"],"drugbank":["DB02546"],"chEBI":["45716"]},"count":82,"approvedIndications":["EFO_0000616","EFO_0002913","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000094631","ENSG00000116478","ENSG00000171720","ENSG00000196591"],"count":4},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0000873","EFO_0004708","EFO_0000365","EFO_0000756","EFO_0000681","EFO_0000249","MONDO_0000956","EFO_1000657","EFO_1001110","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0000588","EFO_0000096","EFO_0000339","MONDO_0003268","MONDO_0019460","MONDO_0008903","EFO_0000330","EFO_0000641","MONDO_0015277","EFO_0003828","EFO_1000785","EFO_0000692","EFO_0000198","EFO_0002618","EFO_0003893","MONDO_0019465","EFO_0000220","MONDO_0008170","EFO_0000180","EFO_0000349","EFO_0002939","EFO_1001968","EFO_1000309","EFO_0000224","EFO_0002429","MONDO_0008315","EFO_0000384","MONDO_0001879","EFO_1001967","EFO_1000026","MONDO_0002691","Orphanet_398934","MONDO_0044787","EFO_0000574","EFO_1001051","EFO_0001378","MONDO_0021640","EFO_0000292","EFO_0002938","Orphanet_232","EFO_0002913","EFO_1001465","MONDO_0007254","EFO_1001469","MONDO_0021063","MONDO_0002087","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_1000044","EFO_1001380","EFO_0006352","EFO_0000770","EFO_1001830","MONDO_0001657","EFO_0000673","EFO_0002499","EFO_0000183","EFO_1000158","EFO_0000479","EFO_0000616","EFO_1000616","EFO_0005774","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0007576","MONDO_0000870","EFO_0002501","EFO_0007535","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0006861","EFO_0000095","EFO_0000764","EFO_0000702","EFO_0000191","MONDO_0018906","EFO_0000691","EFO_0000519","MONDO_0044926"],"count":97},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 79 investigational indications."}
